Protocols, technology and processes matter. But every study still depends on people making thousands of decisions under real-world pressure.
In The Human Side of Clinical Trials, Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., explores how learning, cognition, behavior and human performance influence trial execution.
Published by Applied Clinical Trials and sponsored by ArcheMedX, the podcast series brings together experts across clinical research, human performance, behavioral science and cognitive science to examine where risk begins, how it can be recognized earlier and what can be done to better prepare the people responsible for bringing a protocol to life.
A new conversation about clinical trial performance starts here. Published by Applied Clinical Trials and sponsored by ArcheMedX, the new podcast series explores a simple but often overlooked reality: every clinical trial depends on human performance. In the first episode,
The earliest signs of trial risk may appear before the first patient is ever enrolled. Training completion tells you who finished. It does not necessarily tell you who is prepared
A new conversation about clinical trial performance starts here. Published by Applied Clinical Trials and sponsored by ArcheMedX, the new podcast series explores a simple but often overlooked reality: every
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
